DEA Signals Readiness to Extend Telehealth and Prescribing Flexibilities for a Fourth Year - Behavioral Health Business
DEA signals readiness to extend telehealth prescribing flexibilities for a fourth year, maintaining current allowances for controlled substance prescribing via telemedicine without an in-person visit.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers should confirm how it applies to their specific situation before acting. There is a time constraint attached: Current flexibilities expire at end of public health emergency; extension expected before then.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA indicates it will extend the COVID-19 telehealth prescribing flexibilities for a fourth year, preserving the ability to prescribe controlled substances via telemedicine without an initial in-person exam.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, e-prescribers
What you must do
Monitor DEA for formal extension notice; no immediate action required but prepare for potential permanent rulemaking.
Deadline
Current flexibilities expire at end of public health emergency; extension expected before then.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- DEA Proposes a Special Registry for Telehealth Providers of Controlled Substances - MedPage Today
- DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain - McDermott+
- DEA Extends Telemedicine Flexibilities for Ketamine Prescribing: What Clinics Need to Know in 2026 - JD Supra
- Georgia medical board will limit virtual prescriptions - Atlanta Journal-Constitution
- DEA Proposed Telemedicine Prescribing Rule Could Burden Hospice Physicians and Hospice Operations - Morgan Lewis